{"pub": "investingcom", "url": "https://investing.com/analysis/medicines-company-mdco-jumps-stock-rises-55-200468229", "downloaded_at": "2019-09-26 15:38:39.296699+00:00", "title": "Medicines Company (MDCO) Jumps: Stock Rises 5.5%", "language": "en", "text": "The Medicines Company (NASDAQ: ) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company\u2014as the stock is now up 42% in the past one-month time frame.\n\nThe stock gained after the company announced positive topline results for ORION-10 phase 3 clinical study of Inclisiran in patients with atherosclerotic cardiovascular disease.\n\nThe company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.\n\nMedicines Company currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.\n\nThe Medicines Company Price\n\nInvestors interested in the Medical - Biomedical and Genetics industry may consider Acorda Therapeutics, Inc. (NASDAQ: ) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today\u2019s Zacks #1 Rank stocks here.\n\nIs MDCO going up? Or down? Predict to see what others think:Up or Down\n\nLooking for Stocks with Skyrocketing Upside?\n\nZacks has just released a Special Report on the booming investment opportunities of legal marijuana.\n\n\n\nIgnited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.\n\nSee the pot trades we're targeting>>", "description": "Stocks Analysis by Zacks Investment Research covering: Acorda Therapeutics Inc, The Medicines Company. Read Zacks Investment Research's latest article on Investing.com", "authors": [], "top_image": "https://i-invdn-com.akamaized.net/redesign/images/seo/investingcom_analysis_og.jpg", "published_at": "2019-09-26"}